Personalized dosing aims to tame dangerous TB drug side effects
Disease control
Not yet recruiting
This study aims to make a powerful drug for drug-resistant tuberculosis safer. It will test if checking drug levels in a patient's blood and adjusting the dose accordingly can reduce serious side effects, like nerve damage, while still curing the infection. The research will invo…
Phase: PHASE4 • Sponsor: Marco Schiuma • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC